日本におけるバイオテクノロジーの業界プロファイルは、市場規模（2019〜2024年の価値、および2029年までの予測）を含む、定性的および定量的な概要情報を提供します。また、主要財務指標を含む主要プレーヤーの説明と、市場における競争圧力の分析も含まれています。
目次
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the key players?
7.2. What strategies do the key players follow?
7.3. What have been the most recent market developments?
8 Company Profiles
8.1. Takeda Pharmaceutical Co Ltd
8.2. Astellas Pharma Inc
8.3. Kyowa Kirin Co Ltd
8.4. Chugai Pharmaceutical Co Ltd
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. About MarketLine
List of Tables
Table 1: Japan biotechnology industry value: $ million, 2019-24
Table 2: Japan biotechnology industry category segmentation: % share, by value, 2019-24
Table 3: Japan biotechnology industry category segmentation: $ million, 2019-24
Table 4: Japan biotechnology industry geography segmentation: $ million, 2024
Table 5: Japan biotechnology industry value forecast: $ million, 2024-29
Table 6: Takeda Pharmaceutical Co Ltd: Key Facts
Table 7: Takeda Pharmaceutical Co Ltd: Annual Financial Ratios
Table 8: Takeda Pharmaceutical Co Ltd: Key Employees
Table 9: Astellas Pharma Inc: Key Facts
Table 10: Astellas Pharma Inc: Annual Financial Ratios
Table 11: Astellas Pharma Inc: Key Employees
Table 12: Kyowa Kirin Co Ltd: Key Facts
Table 13: Kyowa Kirin Co Ltd: Annual Financial Ratios
Table 14: Kyowa Kirin Co Ltd: Key Employees
Table 15: Kyowa Kirin Co Ltd: Key Employees Continued
Table 16: Chugai Pharmaceutical Co Ltd: Key Facts
Table 17: Chugai Pharmaceutical Co Ltd: Annual Financial Ratios
Table 18: Chugai Pharmaceutical Co Ltd: Key Employees
Table 19: Japan Size of Population (Million), 2019-24
Table 20: Japan Real GDP (Constant 2010 Prices, $ Billion), 2019-24
Table 21: Japan GDP (Current Prices, $ Billion), 2019-24
Table 22: Japan Inflation, 2019-24
Table 23: Japan Consumer Price Index (Absolute), 2019-24
Table 24: Japan Exchange Rate, 2019-24
List of Figures
Figure 1: Japan biotechnology industry value: $ million, 2019-24
Figure 2: Japan biotechnology industry category segmentation: $ million, 2019-24
Figure 3: Japan biotechnology industry geography segmentation: % share, by value, 2024
Figure 4: Japan biotechnology industry value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the biotechnology industry in Japan, 2024
Figure 6: Drivers of buyer power in the biotechnology industry in Japan, 2024
Figure 7: Drivers of supplier power in the biotechnology industry in Japan, 2024
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Japan, 2024
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Japan, 2024
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Japan, 2024
